A Phase 3, Long Term Open Label Study to Evaluate the Safety of Twice Daily Tacrolimus Cream-B 0.1% in the Treatment of Psoriasis

1% effort 5 subjects

Awarded By

  • Astellas

Contributors

Amount

  • $83,845.00

Start/End

  • January 16, 2006 - January 31, 2008